Covid-19 vaccination and possible link to Herpes zoster

PURPOSE: To report 3 otherwise healthy patients with Herpes zoster reactivation shortly after administration of a mRNA vaccine against the novel COVID-19 virus. OBSERVATIONS: Patient 1 is a 54 year old who presented with Herpes zoster meningitis complicated by enhancing nodular leptomeningeal lesion...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzaro, D.R., Ramachandran, R., Cohen, E., Galetta, S.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789478/
https://www.ncbi.nlm.nih.gov/pubmed/35097240
http://dx.doi.org/10.1016/j.ajoc.2022.101359
_version_ 1784639774213013504
author Lazzaro, D.R.
Ramachandran, R.
Cohen, E.
Galetta, S.L.
author_facet Lazzaro, D.R.
Ramachandran, R.
Cohen, E.
Galetta, S.L.
author_sort Lazzaro, D.R.
collection PubMed
description PURPOSE: To report 3 otherwise healthy patients with Herpes zoster reactivation shortly after administration of a mRNA vaccine against the novel COVID-19 virus. OBSERVATIONS: Patient 1 is a 54 year old who presented with Herpes zoster meningitis complicated by enhancing nodular leptomeningeal lesions of the spinal cord. The subsequent two patients had Herpes zoster ophthalmicus of the cornea (Case 2) and eyelid (Case 3). All three presented within 2 weeks of receiving the Pfizer/BioNTech COVID-19 vaccine. CONCLUSIONS: Herpes zoster may be a side effect of m RNA vaccination against the Sars-CoV2 vaccine and requires further investigation.
format Online
Article
Text
id pubmed-8789478
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87894782022-01-26 Covid-19 vaccination and possible link to Herpes zoster Lazzaro, D.R. Ramachandran, R. Cohen, E. Galetta, S.L. Am J Ophthalmol Case Rep Case Report PURPOSE: To report 3 otherwise healthy patients with Herpes zoster reactivation shortly after administration of a mRNA vaccine against the novel COVID-19 virus. OBSERVATIONS: Patient 1 is a 54 year old who presented with Herpes zoster meningitis complicated by enhancing nodular leptomeningeal lesions of the spinal cord. The subsequent two patients had Herpes zoster ophthalmicus of the cornea (Case 2) and eyelid (Case 3). All three presented within 2 weeks of receiving the Pfizer/BioNTech COVID-19 vaccine. CONCLUSIONS: Herpes zoster may be a side effect of m RNA vaccination against the Sars-CoV2 vaccine and requires further investigation. Elsevier 2022-01-26 /pmc/articles/PMC8789478/ /pubmed/35097240 http://dx.doi.org/10.1016/j.ajoc.2022.101359 Text en © 2022 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Lazzaro, D.R.
Ramachandran, R.
Cohen, E.
Galetta, S.L.
Covid-19 vaccination and possible link to Herpes zoster
title Covid-19 vaccination and possible link to Herpes zoster
title_full Covid-19 vaccination and possible link to Herpes zoster
title_fullStr Covid-19 vaccination and possible link to Herpes zoster
title_full_unstemmed Covid-19 vaccination and possible link to Herpes zoster
title_short Covid-19 vaccination and possible link to Herpes zoster
title_sort covid-19 vaccination and possible link to herpes zoster
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789478/
https://www.ncbi.nlm.nih.gov/pubmed/35097240
http://dx.doi.org/10.1016/j.ajoc.2022.101359
work_keys_str_mv AT lazzarodr covid19vaccinationandpossiblelinktoherpeszoster
AT ramachandranr covid19vaccinationandpossiblelinktoherpeszoster
AT cohene covid19vaccinationandpossiblelinktoherpeszoster
AT galettasl covid19vaccinationandpossiblelinktoherpeszoster

Ejemplares similares